Digil Das Chakkiyath
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Digil Das Chakkiyath has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Artemii Bogomolov
National Pirogov Memorial Medical University, Vinnytsia, Ukraine
1 shared publication M.V. Dobizha
MNCE Vinnytsia Regional Children’s Clinical Hospital of the Vinnytsia Regional Council, Ukraine
1 shared publication- O.A. Moravska
National Pirogov Memorial Medical University, Vinnytsia, Ukraine; MNCE Vinnytsia Regional Children’s Clinical Hospital of the Vinnytsia Regional Council, Ukraine
1 shared publication T.P. Nezhyvenko
MNCE Vinnytsia Regional Children’s Clinical Hospital of the Vinnytsia Regional Council, Ukraine
1 shared publication- Олена Геннадіївна Мазур
National Pirogov Memorial Medical University, Vinnytsia, Ukraine
1 shared publication
Latest Publications
- Open Access
- 28 June 2026
- Published by Group of Companies Med Expert, LLC in UKRAINIAN JOURNAL OF PERINATOLOGY AND PEDIATRICS
- No. 2(106),p. 150-155
Bronchopulmonary dysplasia in the context of Down syndrome in a preterm infant: case report and literature review
Bronchopulmonary dysplasia (BPD) remains one of the most significant chronic complications of prematurity. Infants with Down syndrome represent a particularly vulnerable group due to structural lung abnormalities, hypotonia, and a high prevalence of congenital heart defects, which may worsen respiratory outcomes. The coexistence of prematurity and chromosomal pathology increases the risk of severe pulmonary morbidity. Aim - to analyze the multifactorial development of bronchopulmonary dysplasia (BPD) in a prematurely born infant with Down syndrome and a congenital heart defect, based on a clinical case. Clinical case of a male infant born at 30 weeks of gestation with prenatally confirmed trisomy 21 (Down syndrome). The early neonatal period was complicated by respiratory distress syndrome, congenital pneumonia, and grade III respiratory failure, in combination with congenital cardiovascular anomalies, which required mechanical ventilation for 4 days, followed by nCPAP (nasal continuous positive airway pressure) and prolonged oxygen therapy. At a post-conceptual age of over 36 weeks, radiographic and ultrasound findings demonstrated features consistent with severe BPD. The infant required staged respiratory support, antibacterial therapy, infusion therapy, and multidisciplinary management. Gradual stabilization was achieved, and the child was discharged at 2.5 months of age in satisfactory condition. Conclusion. This case illustrates the multifactorial development of BPD in a premature infant with Down syndrome and congenital heart disease. Early recognition of high-risk patients and coordinated multidisciplinary care are essential to improve outcomes and ensure appropriate long-term follow-up. The research was carried out in accordance with the principles of the Declaration of Helsinki. The informed consent from the patients was obtained for conducting the studies. The authors declare no conflict of interest.
- 28 June 2026
- Published by Group of Companies Med Expert, LLC in UKRAINIAN JOURNAL OF PERINATOLOGY AND PEDIATRICS
- No. 2(106),p. 150-155
Open AccessBronchopulmonary dysplasia in the context of Down syndrome in a preterm infant: case report and literature review
Bronchopulmonary dysplasia (BPD) remains one of the most significant chronic complications of prematurity. Infants with Down syndrome represent a particularly vulnerable group due to structural lung abnormalities, hypotonia, and a high prevalence of congenital heart defects, which may worsen respiratory outcomes. The coexistence of prematurity and chromosomal pathology increases the risk of severe pulmonary morbidity. Aim - to analyze the multifactorial development of bronchopulmonary dysplasia (BPD) in a prematurely born infant with Down syndrome and a congenital heart defect, based on a clinical case. Clinical case of a male infant born at 30 weeks of gestation with prenatally confirmed trisomy 21 (Down syndrome). The early neonatal period was complicated by respiratory distress syndrome, congenital pneumonia, and grade III respiratory failure, in combination with congenital cardiovascular anomalies, which required mechanical ventilation for 4 days, followed by nCPAP (nasal continuous positive airway pressure) and prolonged oxygen therapy. At a post-conceptual age of over 36 weeks, radiographic and ultrasound findings demonstrated features consistent with severe BPD. The infant required staged respiratory support, antibacterial therapy, infusion therapy, and multidisciplinary management. Gradual stabilization was achieved, and the child was discharged at 2.5 months of age in satisfactory condition. Conclusion. This case illustrates the multifactorial development of BPD in a premature infant with Down syndrome and congenital heart disease. Early recognition of high-risk patients and coordinated multidisciplinary care are essential to improve outcomes and ensure appropriate long-term follow-up. The research was carried out in accordance with the principles of the Declaration of Helsinki. The informed consent from the patients was obtained for conducting the studies. The authors declare no conflict of interest.
- Open Access
- 19 December 2025
- Published by National Scientific Center of Phthisiology, Pulmonology, and Allergology named after F. G. Yanovsky NAMS of Ukraine in Asthma and allergy
- Vol. 24 (4)
The Role of Artificial Intelligence in Allergology and Immunology: from Diagnosis to Prediction
Artificial intelligence (AI) and machine learning (ML) are rapidly transforming the field of allergy and immunology, offering innovative solutions for diagnosis, optimization, and personalization of patient care and treatment. This review examines current applications of AI in clinical allergy practice, ethical considerations, patient-centered technologies, educational requirements, and future directions. Based on a systematic literature search in PubMed, which included 19 relevant articles published between 2022 and 2025. We analyzed the integration of AI tools into natural language processing systems, clinical decision support algorithms, mobile health applications, and prognostic models. Although AI demonstrates significant potential in increasing diagnostic accuracy, personalizing treatment strategies, and improving patient outcomes, critical challenges remain regarding data privacy, transparency, clinical validation, and professional training. The emergence of explainable AI and digital twin technology are promising directions for precision medicine in allergology. However, successful implementation requires close attention to ethical frameworks, compliance with regulatory requirements, and preservation of human clinical expertise in patient care.
- 19 December 2025
- Published by National Scientific Center of Phthisiology, Pulmonology, and Allergology named after F. G. Yanovsky NAMS of Ukraine in Asthma and allergy
- Vol. 24 (4)
Open AccessThe Role of Artificial Intelligence in Allergology and Immunology: from Diagnosis to Prediction
Artificial intelligence (AI) and machine learning (ML) are rapidly transforming the field of allergy and immunology, offering innovative solutions for diagnosis, optimization, and personalization of patient care and treatment. This review examines current applications of AI in clinical allergy practice, ethical considerations, patient-centered technologies, educational requirements, and future directions. Based on a systematic literature search in PubMed, which included 19 relevant articles published between 2022 and 2025. We analyzed the integration of AI tools into natural language processing systems, clinical decision support algorithms, mobile health applications, and prognostic models. Although AI demonstrates significant potential in increasing diagnostic accuracy, personalizing treatment strategies, and improving patient outcomes, critical challenges remain regarding data privacy, transparency, clinical validation, and professional training. The emergence of explainable AI and digital twin technology are promising directions for precision medicine in allergology. However, successful implementation requires close attention to ethical frameworks, compliance with regulatory requirements, and preservation of human clinical expertise in patient care.